<DOC>
	<DOCNO>NCT00186394</DOCNO>
	<brief_summary>To evaluate role allogeneic hematopoietic cell transplantation treatment NHL .</brief_summary>
	<brief_title>High Dose Chemotherapy Allogeneic Hematopoietic Cell Transplant Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description>To determine safety toxicity regimen high dose chemotherapy allogeneic peripheral blood progenitor cell transplantation ; determine efficacy procedure follow clinical outcome quality life measure ; evaluate graft versus host disease incidence severity regimen .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>Morphologically confirm relapsed nonHodgkin 's lymphoma Age : &gt; 18 &lt; 61 year age Signed informed consent Hepatic dysfunction define serum transaminase &gt; 2.5X normal value Serum creatinine &gt; 2 mg/dl creatinine clearance &lt; 60 ml/min Diseases nonHodgkin 's lymphoma Prior bone marrow transplant procedure Severe psychological medical illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>61 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>